syngo.MR OncoTrend1 allows the assessment and intuitive visualization of changes in functional imaging parameters, i.e. diffusion characteristics (ADC values) under therapy.
With a color-coding of different ADC value ranges and overlay of post-processing results in the original images, multiple timepoints can be compared and changes can easily be assessed.
With its histogram analysis, back-mapping, and trending functionalities, syngo.MR OncoTrend offers a solution for semi-quantitative evaluation of functional lesion response to treatment. It has the potential to allow earlier assessment of treatment response, leading to treatment path optimization and savings of unnecessary treatment costs.
syngo.MR OncoTrend
¿Fue útil esta información?
1
Pending 510k clearance and not yet commercially available in all countries. Its future availability cannot be guaranteed.